Utility of <sup>99 m</sup>Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice

DOI Web Site 7 Citations 16 References
  • Tsutsui Yoshitomo
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University
  • Kubota Toru
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
  • Kato Seiya
    Division of Pathology, Saiseikai Fukuoka General Hospital
  • Nozoe Masatsugu
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
  • Suematsu Nobuhiro
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
  • Okabe Masanori
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
  • Yamamoto Yusuke
    Division of Cardiology, Cardiovascular and Aortic Center, Saiseikai Fukuoka General Hospital
  • Tsutsui Hiroyuki
    Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

Bibliographic Information

Other Title
  • Utility of 99mTc-pyrophosphate scintigraphy in diagnosing transthyretin cardiac amyloidosis in real-world practice

Search this article

Abstract

<p>Background:Amyloid transthyretin (ATTR) cardiac amyloidosis has now been recognized as one of the major causes of heart failure, especially in elderly patients. The purpose of the present study was to validate the usefulness of technetium-99 m (99 mTc)-pyrophosphate (99 mTc-PYP) scintigraphy in the screening diagnosis for ATTR amyloidosis in daily clinical practice.</p><p>Methods and Results:Ninety-eight patients underwent 99 mTc-PYP scintigraphy in the previous 3 years (PYP positive/negative, 18/80), of whom 29 underwent concomitant endomyocardial biopsy (ATTR positive/negative, 9/20). The sensitivity and specificity of 99 mTc-PYP scintigraphy for the diagnosis of biopsy-proven ATTR amyloidosis were 0.889 and 0.950, respectively. Age, gender, N-terminal prohormone of brain natriuretic peptide (NT-proBNP) level, or electrocardiogram findings did not differ significantly between PYP-positive and PYP-negative patients. Left ventricular (LV) wall thickness was significantly greater in PYP-positive than in PYP-negative patients, but LV ejection fraction or prevalence of atrial fibrillation was similar between groups. In the PYP-positive patients, higher uptake of PYP correlated with younger age and lower NT-proBNP.</p><p>Conclusions: 99 mTc-PYP scintigraphy was useful, with high sensitivity and specificity in the screening diagnosis for ATTR cardiac amyloidosis, which is difficult to diagnose on clinical characteristics alone. 99 mTc-PYP scintigraphy should be considered to elucidate the underlying causes of heart failure, especially in elderly patients based on the higher prevalence of ATTR cardiac amyloidosis in this population.</p>

Journal

  • Circulation Reports

    Circulation Reports 1 (7), 277-285, 2019-07-10

    The Japanese Circulation Society

Citations (7)*help

See more

References(16)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top